Rapid detection within 15 min,Positive results may be visible in as short as 1 minute.

No testing equipments required.

IgM and IgG Antibodies

Both IgM and IgG are immunoglobulin which are produced by the immune system to provide protection

against the 2019-nCoV. Some patients with negative results in nucleic acid test show positive in IgM test,

indicating that the IgG / IgM detection is one of the effective methods for the diagnosis of 2019-nCoV.

The level of IgM antibody begins to rise after 1 week after the initial infection, while the IgG appears later

than IgM (usually in 14 days after infection) and can last for 6 months or even several years, which means

that the IgG serves as an indicator of previous infection.

Suspected patients that are infected by 2019-nCoV can be rapidly identified by simultaneous monitoring of IgM and IgG. During the outbreak period of 2003-SARS and the 2016-Zika, IgM / IgG antibody detection was used as one of the recommended diagnostic methods.

Advantages of IgG / IgM Detection

1. Indicating both recent infections and previous infections, reducing missed detection rates.

2. Low requirements of instruments; suitable for primary hospitals and conventional outpatient clinics.

3. Blood testing; low requirements for sampling; no special virus collection tube required.

4. Suitable for combined detection with nucleic-acid testing kit to improve thediagnosis rate of suspected patients.

Product Advantages

1. Read results at 15 minutes. Positive results may be visible in as short as 1 minute

2. High detection efficiency: simultaneous monitoring of IgM and IgG.

3. Detection without any testing equipments .

4. Easy to operate, and is compatible with serum/ whole blood/ plasma.

5. Room-temperature（(4-30°C） storage.

Workflow and Interpreting Test Results

Product Information

Produced by: Suzhou Kangheshun Medical Technology Co., Ltd.

Address: Room 403-3, Building 29, 369 Lushan Road, Suzhou High-tech Zone, Suzhou Jiangsu P.R. China

Phone: +86-512-66893470